文献速递糖尿病

孕早期白大衣高血压在孕前糖尿病女性中的患病率及妊娠结局

White coat hypertension in early pregnancy in women with pre-existing diabetes: prevalence and pregnancy outcomes.
PubMed 文献 · Diabetologia · 2019-10-18

这项前瞻性队列研究纳入222例孕前糖尿病女性,基于孕早期诊室血压和3天家庭血压,发现新检出诊室血压≥135/85 mmHg者中84%为白大衣高血压,占全队列12%(95%CI 8%,17%)。白大衣高血压组妊娠期高血压疾病发生率为44%(12/27),显著高于血压正常组的22%(36/163)(p=0.013),校正后分析提示风险约翻倍(OR 2.43 [CI 0.98, 6.05])。

要点

  • 孕前糖尿病女性孕早期新发诊室血压升高者中,白大衣高血压占84%。
  • 白大衣高血压与后续妊娠期高血压疾病风险升高相关,校正后OR 2.43(CI 0.98, 6.05)。
  • 诊室血压升高时应重复家庭血压监测,以区分白大衣高血压与妊娠期高血压。

核心结论

  • 白大衣高血压在孕前糖尿病女性中常见,可能提示后续妊娠期高血压疾病高风险。
  • 诊室血压升高时应重复家庭血压监测,以区分持续性白大衣高血压与妊娠期高血压发病。

研究设计与样本

  • 前瞻性队列研究,纳入地理区域明确的孕前糖尿病女性222例。
  • 根据孕早期诊室血压和3天家庭血压分为白大衣高血压、慢性高血压和血压正常三组。
  • 白大衣高血压定义为诊室血压≥135/85 mmHg且平均家庭血压<130/80 mmHg。
  • 慢性高血压定义为孕前高血压,包括新检出诊室血压≥135/85 mmHg且家庭血压≥130/80 mmHg。
  • 研究注册于ClinicalTrials.gov(ID: NCT02890836)。

主要发现

  • 222例中32例孕早期新检出诊室血压≥135/85 mmHg,其中84%(27/32)为白大衣高血压,占全队列12%(95%CI 8%,17%)。
  • 慢性高血压占14%(n=32),血压正常占74%(n=163)。
  • 白大衣高血压组相比血压正常组,孕前BMI更高(p=0.011)、家庭血压更高(p<0.001)、2型糖尿病患病率更高(p=0.009),HbA1c相似(p=0.409)。
  • 白大衣高血压组妊娠期高血压疾病发生率为44%(12/27),血压正常组为22%(36/163)(p=0.013);早产率相当(p=0.143)。
  • 事后校正分析提示,孕早期白大衣高血压者发生妊娠期高血压疾病的风险约翻倍(OR 2.43 [CI 0.98, 6.05]),独立于孕前BMI和产次。

关键数值与推荐

  • 白大衣高血压:诊室血压≥135/85 mmHg且平均家庭血压<130/80 mmHg。
  • 慢性高血压:孕前高血压,包括新检出诊室血压≥135/85 mmHg且家庭血压≥130/80 mmHg。
  • 妊娠期高血压疾病:诊室血压≥140/90 mmHg且家庭血压(如有)≥130/80 mmHg,妊娠20周后发病。
  • 白大衣高血压不予治疗;诊室血压≥135/85 mmHg且家庭血压≥130/80 mmHg时启动严格降压治疗。

临床怎么用

  • 孕前糖尿病女性孕早期应监测诊室血压,升高时进行家庭血压监测以识别白大衣高血压。
  • 白大衣高血压者后续需警惕妊娠期高血压疾病,重复家庭血压监测有助于区分持续性白大衣高血压与妊娠期高血压。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Hypertensive disorders are prevalent among pregnant women with pre-existing diabetes, but the prevalence and impact of white coat hypertension are unknown. Measurement of home BP before initiation of antihypertensive treatment is necessary to identify white coat hypertension since international guidelines recommend that white coat hypertension is left untreated. The aim of this study, conducted among women with pre-existing diabetes, was therefore to examine the prevalence of white coat hypertension in early pregnancy, and pregnancy outcome in women with white coat hypertension in early pregnancy. METHODS: A prospective cohort study was undertaken involving women with pre-existing diabetes from a geographically well-defined area. Based on office BP in early pregnancy and home BP measured for 3 days, women were categorised in three groups: (1) white coat hypertension, defined as office BP ≥ 135/85 mmHg and mean home BP < 130/80 mmHg; (2) chronic hypertension, defined as pre-pregnancy hypertension including newly detected office BP ≥ 135/85 mmHg with home BP ≥ 130/80 mmHg; and (3) normotension. Office BP was measured every 2 weeks and, if ≥ 135/85 mmHg, home BP measurements were performed. White coat hypertension was left untreated, and tight antihypertensive treatment was initiated when both office BP ≥ 135/85 mmHg and home BP ≥ 130/80 mmHg. Pregnancy-induced hypertensive disorders were defined as office BP ≥ 140/90 mmHg with home BP ≥ 130/80 mmHg when available, with onset after 20 weeks of gestation. RESULTS: In total, 32 out of 222 women with pre-existing diabetes had newly detected office BP ≥ 135/85 mmHg in early pregnancy. White coat hypertension was present in 84% (27/32) of these women, representing 12% (95% CI 8%, 17%) of the whole cohort. Chronic hypertension was present in 14% (n = 32) and normotension in 74% (n = 163). Women with white coat hypertension were characterised by higher pre-pregnancy BMI (p = 0.011), higher home BP (p < 0.001) and higher prevalence of type 2 diabetes (p = 0.009), but similar HbA1c (p = 0.409) compared to women with normotension. Regarding pregnancy outcome, pregnancy-induced hypertensive disorders developed in 44% (12/27) of women with white coat hypertension in comparison with 22% (36/163) among initially normotensive women (p = 0.013), while the prevalence of preterm delivery was comparable (p = 0.143). The adjusted analysis, performed post hoc, suggested approximately double the risk of developing pregnancy-induced hypertensive disorders (OR 2.43 [CI 0.98, 6.05]) if white coat hypertension was present in early pregnancy, independently of pre-pregnancy BMI and parity. CONCLUSIONS/INTERPRETATION: White coat hypertension is prevalent in women with pre-existing diabetes and may indicate a high risk of later development of pregnancy-induced hypertensive disorders. To distinguish between persistent white coat hypertension and onset of pregnancy-induced hypertension, repeated home BP monitoring is recommended when elevated office BP is detected. The study was registered at ClinicalTrials.gov (ID: NCT02890836).

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Vestgaard M, Ásbjörnsdóttir B, Ringholm L, et al. White coat hypertension in early pregnancy in women with pre-existing diabetes: prevalence and pregnancy outcomes. Diabetologia. 2019. PMID: 31628489. doi:10.1007/s00125-019-05002-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。